News

Zambon exits inhaler pact

Zambon exits inhaler pact

The march towards multidrug therapy of asthma has caused Italy's
Zambon to pull out of a research project aimed at developing new
inhaler formulations of the steroid budesonide and bronchodilator
formoterol.

People on the move

People on the move

In-Pharmatechnologist's periodic round up of personnel moves in the
pharmaceutical sector includes a crop of new chief executives and
senior managers across the pharmachem, drug development and
manufacturing sectors.

Follow us

Products

View more

Webinars